Chinese Health Ivvestigation Of Nurse Aging

Hot Flashes Clinical Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01994655
• Other study ID #: PEK-8357-wp
• Status: Active, not recruiting
• Phase: Phase 1/Phase 2
• First received: November 20, 2013
• Last updated: November 20, 2013
• Start date: August 2008
• Est. completion date: September 2016

Study information

• Verified date: November 2013
• Source: Peking University First Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

Climacteric symptoms can be treated by doing exercise,not hormone replacement therapy.

Description:

Hormone replacement therapy(HRT) is the main therapy to climacteric symptoms. But HRT also has a lot of disadvantages, such as cardiovascular disease, breast cancer .In our previous investigation,we found that doing exercise is helpful for climacteric symptoms.So we want to make a detailed investigation to research it.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 2000
• Est. completion date: September 2016
• Est. primary completion date: September 2015
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 40 Years to 55 Years

Eligibility

Inclusion Criteria:

• Women aged 40-55 who has climacteric symptoms

Exclusion Criteria:

• Women who have serious climacteric symptoms and other diseases which could interrupt the research.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Hot Flashes

Intervention

Other:
• Doing exercise
We want to investigate the effects of exercise on climacteric symptoms
• Doing exercise
Doing exercise at least 6 months including walking, running, yoga etc.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Bai Wen-Pei

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	KMI	KMI is the short of Kupperman Index,which is a questionnaire to assesses the severity of climacteric symptoms.	up to 2 years	Yes
Secondary	blood lipid	Blood lipid is an index to assess the effect of doing exercise.	up to 2 years	Yes